IHS Chemical Week

People & Business :: Earnings/Finance

Bayer reports higher sales and profits; ups pharma pipeline estimate

6:00 AM MST | February 28, 2014 | Natasha Alperowicz in Leverkusen

Bayer today reported higher sales and profits for the fourth quarter and full-year 2013 and gave a forecast for this year hoping to grow sales by about 5% on a currency- and portfolio-adjusted basis. Marijn Dekkers, chairman of Bayer, speaking at a press briefing in Leverkusen, said that the company’s five recently launched pharmaceutical products have a much higher peak sales potential than originally estimated. Meanwhile, Werner Baumann, CFO in response to a question on why Bayer continues to own Bayer MaterialScience (BMS), a business that does not have...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa